热门资讯> 正文
Ensys Biosciences重新获得纳斯达克合规性
2024-05-28 20:48
- Ensysce Biosciences (NASDAQ:ENSC) said it got a notice from Nasdaq, stating that the company has regained compliance.
- As a result, Ensysce common stock will continue trading on Nasdaq's Capital Market tier.
More on Ensysce Biosciences
- Ensysce Biosciences reports Q4 results
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。